Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
August 23, 2022
Health burden and economic loss attributable to ambient PM<sub>2.5</sub> in Iran based on the ground and satellite data
Sasan Faridi, Reza Bayat, Aaron J Cohen, et al.
Cancers
|
July 24, 2021
The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy
Reza Bayat Mokhtari, Manpreet Sambi, Bessi Qorri, et al.
Biomedicines
|
January 28, 2026
HER2-Low Breast Cancer at the Interface of Pathology and Technology: Toward Precision Management
Faezeh Shekari, Reza Bayat Mokhtari, Razieh Salahandish, et al.
Molecular Genetics & Genomic Medicine
|
March 23, 2026
Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review
Arash Salmaninejad, Mohammad Reza Seyedtaghia, Ali Hosseini Bereshneh, et al.
Frontiers in Immunology
|
October 17, 2022
Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense
Seema Bhuyan, Bidisha Pal, Lekhika Pathak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2011
Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor
Sushil Kumar, Reza Bayat Mokhtari, Reihaneh Sheikh, et al.
Translational Oncology
|
May 27, 2018
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models
Sushil Kumar, Jessica D Sun, Libo Zhang, et al.
Oncotarget
|
July 28, 2021
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Reza Bayat Mokhtari, Bessi Qorri, Narges Baluch, et al.
Oncotarget
|
September 12, 2022
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Reza Bayat Mokhtari, Bessi Qorri, Narges Baluch, et al.
Biomolecules
|
September 27, 2025
A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine
Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
August 23, 2022
Health burden and economic loss attributable to ambient PM<sub>2.5</sub> in Iran based on the ground and satellite data
Sasan Faridi, Reza Bayat, Aaron J Cohen, et al.
Cancers
|
July 24, 2021
The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy
Reza Bayat Mokhtari, Manpreet Sambi, Bessi Qorri, et al.
Biomedicines
|
January 28, 2026
HER2-Low Breast Cancer at the Interface of Pathology and Technology: Toward Precision Management
Faezeh Shekari, Reza Bayat Mokhtari, Razieh Salahandish, et al.
Molecular Genetics & Genomic Medicine
|
March 23, 2026
Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review
Arash Salmaninejad, Mohammad Reza Seyedtaghia, Ali Hosseini Bereshneh, et al.
Frontiers in Immunology
|
October 17, 2022
Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense
Seema Bhuyan, Bidisha Pal, Lekhika Pathak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2011
Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor
Sushil Kumar, Reza Bayat Mokhtari, Reihaneh Sheikh, et al.
Translational Oncology
|
May 27, 2018
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models
Sushil Kumar, Jessica D Sun, Libo Zhang, et al.
Oncotarget
|
July 28, 2021
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Reza Bayat Mokhtari, Bessi Qorri, Narges Baluch, et al.
Oncotarget
|
September 12, 2022
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Reza Bayat Mokhtari, Bessi Qorri, Narges Baluch, et al.
Biomolecules
|
September 27, 2025
A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine
Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, et al.
Page
of 7